SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-021726
Filing Date
2024-07-01
Accepted
2024-07-01 16:31:55
Documents
18
Period of Report
2024-06-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K wint20240630_8k.htm   iXBRL 8-K 54145
2 EXHIBIT 4.1 ex_694342.htm EX-4.1 59541
3 EXHIBIT 4.2 ex_694343.htm EX-4.2 202679
4 EXHIBIT 10.1 ex_694344.htm EX-10.1 439562
5 EXHIBIT 10.2 ex_694345.htm EX-10.2 112273
  Complete submission text file 0001437749-24-021726.txt   1177644

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA wint-20240625.xsd EX-101.SCH 3408
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20240625_def.xml EX-101.DEF 11423
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20240625_lab.xml EX-101.LAB 15309
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20240625_pre.xml EX-101.PRE 11583
20 EXTRACTED XBRL INSTANCE DOCUMENT wint20240630_8k_htm.xml XML 2837
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39290 | Film No.: 241091095
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)